The role of iron in the proliferation of Drosophila l(2)mbn cells

Biochemical and Biophysical Research Communications

Volumn 400, Issue 3, 2010, Pages 442-446

  Metzendorf, Christoph ^a   Lind, Maria I ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cell cycle arrest; Cell proliferation; Cyclin; Drosophila; Iron

Indexed keywords

CELL CYCLE PROTEIN; DEFEROXAMINE; IRON; PROTEIN CYCE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DROSOPHILA; FLUORESCENCE ACTIVATED CELL SORTING; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; ANIMAL; CELL CYCLE; CYTOLOGY; DROSOPHILA MELANOGASTER; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DROSOPHILA MELANOGASTER; GENE EXPRESSION REGULATION; IRON;

HEXAPODA;

EID: 77956896565     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.100     Document Type: Article

References (41)

1. Le N.T.V., Richardson D.R. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim. Biophys. Acta 2002, 1603:31-46.
2. Yu Y., Kovacevic Z., Richardson D.R. Tuning cell cycle regulation with an iron key. Cell Cycle 2007, 6:1982-1994.
3. Hoffbrand A.V., Ganeshaguru K.M., Hooton J.W.L., Tattersall M.H.N. Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br. J. Haematol. 1976, 33:517-526.
4. Nyholm S., Mann G.J., Johansson A.G., Bergeron R.J., Gräslund A., Thelander L. Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators. J. Biol. Chem. 1993, 268:26200-26205.
5. Thelander L., Reichard P. Reduction of ribonucleotides. Annu. Rev. Biochem. 1979, 48:133-158.
6. Alcantara O., Kalidas M., Baltathakis I., Boldt D.H. Expression of multiple genes regulating cell cycle and apoptosis in differentiating hematopoietic cells is dependent on iron. Exp. Hematol. 2001, 29:1060-1069.
7. Nurtjahja-Tjendraputra E., Fu D., Phang J.M., Richardson D.R. Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression. Blood 2007, 109:4045-4054.
8. Fu D., Richardson D.R. Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletion. Blood 2007, 110:752-761.
9. Saletta F., Rahmanto Y.S., Noulsri E., Richardson D.R. Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of HIF-1{alpha} and p53. Mol. Pharmacol. 2010, 77:443-458.
10. Jensen L.J., Jensen T.S., de Lichtenberg U., Brunak S., Bork P. Co-evolution of transcriptional and post-translational cell-cycle regulation. Nature 2006, 443:594-597.
11. Bloom J., Cross F.R. Multiple levels of cyclin specificity in cell-cycle control. Nat. Rev. Mol. Cell Biol. 2007, 8:149-160.
12. Levin A.J., Oren M. The first 30 years of p53: growing ever more complex. Nat. Rev. Cancer 2009, 9:749-758.
13. Sherr C.J. G1 phase progression: cycling on cue. Cell 1994, 79:551-555.
14. Kerberle H. The biochemistry of desferrioxamine and its relation to iron metabolism. Ann. NY Acad. Sci. 1964, 119:758-768.
15. Donfrancesco A., Deb G., Dominici C., Angioni A., Caniglia M., De Sio L., Fidani P., Amici A., Helson L. Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma. Am. J. Clin. Oncol. 1992, 15:319-322.
16. Renton F.J., Jeitner T.M. Cell cycle dependent inhibition of proliferation of human neural tumor cell line by iron chelation. Biochem. Pharmacol. 1996, 51:1553-1561.
17. Buss J.L., Torti F.M., Torti S.V. The role of iron chelation in cancer therapy. Curr. Med. Chem. 2003, 10:1021-1034.
18. Le N.T.V., Richardson D.R. Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. Blood 2004, 104:2967-2975.
19. Whitnall M., Howard J., Ponka P., Richardson D.R. A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics. Proc. Natl. Acad. Sci. USA 2006, 103:14901-14906.
20. Gao J., Richardson D.R. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: the mechanisms involved in inhibiting cell-cycle progression. Blood 2001, 23:247-248.
21. Wong A.K., Chen Y., Lian L., Ha P.C., Petersen K., Laity K., Carillo A., Emerson M., Heichman K., Gupte J., Tavtigian S.V., Teng D.H. Genomic structure, chromosomal location, and mutation analysis of the human CDC14A gene. Genomics 1999, 59:248-251.
22. Patterson K.I., Brummer T., O'Brien P.M., Daly R.J. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem. J. 2009, 418:475-489.
23. Sanchez M., Galy B., Dandekar T., Bengert P., Vainshtein Y., Stolte J., Muckenthaler M.U., Hentze M.W. Iron regulation and the cell cycle: identification of an iron-responsive element in the 3′-untranslated region of human cell division cycle 14A mRNA by a refined microarray-based screening strategy. J. Biol. Chem. 2006, 281:22865-22874.
24. Cmejla R., Petrak J., Cmejlova J. A novel iron responsive element in the 3′UTR of human MRCKalpha. Biochem. Biophys. Res. Commun. 2006, 341:158-166.
25. Lee L.A., Orr-Weaver T.L. Regulation of cell cycles in Drosophila development: instric and extrinic cues. Annu. Rev. Genet. 2003, 37:545-578.
26. Gatef E. Malignant neoplasms of genetic origin in Drosophila melanogaster. Science 1978, 200:1448-1459.
27. Lind M.I., Ekegren S., Melefors Ö., Söderhäll K. Drosophila ferritin mRNA: alternative RNA splicing regulates the presence of the iron responsive element. FEBS Lett. 1998, 436:476-482.
28. Tada H., Shiho O., Kuroshima K., Koyama M., Tsukamoto K. An improved colorimetric assay for interleukin 2. J. Immunol. Methods 1986, 93:157-165.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
30. Metzendorf C., Wu W., Lind M.I. Overexpression of Drosophila mitoferrin in l(2)mbn cells results in dysregulation of Fer1HCH expression. Biochem. J. 2009, 421:463-471.
31. Girardot F., Monnier V., Tricoire H. Genome wide analysis of common and specific stress responses in adult Drosophila melanogaster. BMC Genomics 2004, 5:74-89.
32. Slater T.F., Sawyer B., Sträuli U. Studies on succinate-tetrazolium reductase systems III. Point of coupling of four different tetrazolium salts. Biochim. Biophys. Acta 1963, 77:383-393.
33. Collins J.F., Franck C.A., Kowdley K.V., Ghishan F.K. Identification of differentially expressed genes in response to dietary iron deprivation in rat duodenum. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288:G964-G971.
34. Lehner C.F., O'Farrell P.H. Expression and function of Drosophila cyclin A during embryonic cell cycle progression. Cell 1989, 957-968.
35. Richardson H.E., O'Keefe L.V., Reed S.I., Saint R. A Drosophila G1-specific cyclin E homolog exhibits different modes of expression during embryogenesis. Development 1993, 119:673-690.
36. Dynlacht B.D., Brook A., Dembski M.S., Yenush L., Dyson N. DNA-binding and trans-activation properties by Drosophila E2F and DP proteins. Proc. Natl Acad. Sci. USA 1994, 91:6359-6363.
37. Ohtani K., Nevins J.R. Functional properties of a Drosophila homolog of the E2F1 gene. Mol. Cell. Biol. 1994, 14:1603-1612.
38. Du W., Vidal M., Xie J.-E., Dyson N., RBF N. A novel RB-related gene that regulates E2F activity and interacts with cyclin E in Drosophila. Genes Dev. 1996, 10:1206-1218.
39. Knoblich J.A., Sauer K., Jones L., Richardson H., Saint R., Lehner C.F. Cyclin E controls S-phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell proliferation. Cell 1994, 77:107-120.
40. Duronio R.J., O'Farrell P.H. Developmental control of a G1-S transcriptional program in Drosophila. Development 1994, 120:1503-1515.
41. Fukuchi K., Tomoyasu S., Watanabe H., Tsuruoka N., Gomi K. G1 accumulation caused by iron deprivation with deferoxamine does not accompany change of pRB status in ML-1 cells. Biochim. Biophys. Acta 1997, 1357:297-305.